MULTIPLE MYELOMA PROGRESSION
Clinical trials for MULTIPLE MYELOMA PROGRESSION explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE MYELOMA PROGRESSION trials appear
Sign up with your email to follow new studies for MULTIPLE MYELOMA PROGRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 'Off-the-Shelf' CAR-T therapy takes on Hard-to-Treat myeloma
Disease control Not yet recruitingThis early-phase trial is testing DQ1001, a ready-made CAR-T cell therapy that targets two proteins (BCMA and GPRC5D) on myeloma cells. It is designed for patients whose multiple myeloma has returned or stopped responding to at least three prior treatments. The study will enroll …
Matched conditions: MULTIPLE MYELOMA PROGRESSION
Phase: PHASE1 • Sponsor: Zhongshan Hospital (Xiamen), Fudan University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Why do blood cancer patients skip home care? new study aims to find out.
Knowledge-focused Not yet recruitingThis study looks at why some people with blood cancers like multiple myeloma or lymphoma choose not to receive treatment at home, or are not eligible for it. Researchers will interview patients, their caregivers, and healthcare staff, and review medical records and questionnaires…
Matched conditions: MULTIPLE MYELOMA PROGRESSION
Sponsor: Odense University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC